AG 702

Drug Profile

AG 702

Alternative Names: AG-702; AG-702/X; AG-70X; HSPPC-70-GH

Latest Information Update: 07 Aug 2006

Price : $50

At a glance

  • Originator Antigenics
  • Class
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Herpes simplex virus infections

Most Recent Events

  • 15 Mar 2006 Discontinued - Phase-I/II for Herpes simplex virus infections in USA (unspecified route)
  • 31 Dec 2004 Phase-I/II clinical trials of AG 702 in Herpes simplex virus infections in USA (unspecified route)
  • 25 Mar 2004 This compound is still in active development - (BioSquare-2004)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top